Compounded peptides and medications
A compounded medication is prepared by a licensed pharmacy for an individual prescription rather than manufactured in a factory. It's how providers prescribe compounded peptides and other molecules that have no commercial version and adjust formulations to a patient — and it comes with its own rules: compounded medications are not FDA-approved, and quality depends on the pharmacy's standards.
These articles explain how compounding works, how it's regulated, and what that means for the treatments you're prescribed.
325 articles on this topic
-
Thymosin Alpha 1 News: October 2026 Update
New studies broaden the research questions, while U.S. status remains unchanged. Here is what the July–September quarter adds to a prescribing conversation.
-
Semaglutide Knee Osteoarthritis: What STEP 9 Found
In STEP 9, adults with obesity had greater average knee-pain and weight reductions with semaglutide. The trial did not establish cartilage repair.
-
Tesamorelin Fatty Liver Trial: What It Found
A 12-month trial found less liver fat and less worsening of scarring with tesamorelin. Its 61 participants had HIV, a virus that weakens the immune system, which limits what the findings mean for everyone else.
-
Epitalon Telomeres: What the Studies Actually Show
The claim comes from cells studied outside the body. Those findings haven't established a longer or healthier life for people taking epitalon.
-
Who Discovered NAD? The History Behind NAD+
Harden and Young found NAD's activity in yeast experiments, with a detailed paper in 1906. The vitamin, Nobel and longevity chapters came later.
-
TB-500 Myths: Ten Claims Checked Against Studies
TB-500's benefits in humans have not been established. Ten common claims get graded against the actual molecule, study and outcome behind them.
-
What Is a Bulk Drug Substance? API, Explained
A bulk drug substance is the active ingredient before it becomes a finished medicine. Its exact chemical form, source and batch testing matter.
-
OASIS 4 Trial Results: 13.6% Weight Loss Explained
The daily 25 mg tablet averaged 13.6% weight loss versus 2.2% with placebo at 64 weeks. The 16.6% headline assumes continued treatment.
-
10 Questions to Ask Before PT-141
A PT-141 visit starts with fit and safety. These ten questions clarify the evidence, medical history, side effects, and follow-up plan.
-
Should I Take NAD+? A Provider's Decision Path
The answer starts with your goal and what is causing the tiredness. Oral supplement findings don't establish what NAD+ injections would do for you.
-
Forzinity Prescribing Information: Plain English
Forzinity’s label covers Barth syndrome, a daily injection, and specific safety limits. Here’s what each section means.
-
GHK-Cu Myths: 8 Claims Checked Against Evidence
GHK-Cu has real human research on skin and wounds. That doesn't establish that injections make people younger, regrow hair, or work like a cream.
-
Is Epitalon FDA Approved? It Is Not
Epitalon is not FDA-approved. Its July 2026 committee recommendation concerned a compounding ingredient list, and FDA has not completed that rulemaking.
-
SS-31 News: October 2026 Update
Forzinity's follow-up trial is underway. Fresh mouse and cell studies add research questions, while the label remains limited to Barth syndrome.
-
What Is Bioequivalence? What Generics Must Match
Bioequivalence compares how two medicines reach the body. The 80–125% rule measures study uncertainty, and compounded drugs follow a different route.
-
Semax Side Effects: What the Safety Data Shows
Mild nasal irritation is documented, but reliable rates for other reactions are missing. The small studies leave important safety questions unanswered.
-
Tirzepatide and Pancreatitis: Risk and Symptoms
Pancreatitis is uncommon in tirzepatide trials, but it remains a serious warning. Persistent or severe stomach pain needs urgent medical attention.
-
Who Discovered Thymosin Alpha 1? Goldstein’s Team
Goldstein, White and Slater reported thymosin in 1966. A larger team isolated alpha-1 in 1977, opening the path to synthetic thymalfasin and Zadaxin.
-
GHK-Cu News: October 2026 Update
New skin studies add useful detail about GHK-Cu, while human injection benefits remain unsettled. FDA's ingredient review is still pending.
-
Semaglutide and Menopause: Weight, HRT and Bone
Semaglutide may help with medically appropriate weight management after menopause. Hormone therapy, muscle, bone, and menopause symptoms each need their own place in the care plan.
Page 2 of 17 · 325 articles